IRIS
CHIAPPINI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.078
NA - Nord America 744
SA - Sud America 415
EU - Europa 408
AF - Africa 64
OC - Oceania 4
Totale 2.713
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 681
SG - Singapore 365
BR - Brasile 306
IT - Italia 288
CN - Cina 202
HK - Hong Kong 153
VN - Vietnam 83
IN - India 52
MX - Messico 42
AR - Argentina 36
BD - Bangladesh 30
IQ - Iraq 28
FR - Francia 26
PK - Pakistan 20
EC - Ecuador 19
ID - Indonesia 16
TR - Turchia 16
CO - Colombia 15
PH - Filippine 15
UZ - Uzbekistan 15
DE - Germania 14
GB - Regno Unito 14
ZA - Sudafrica 14
MY - Malesia 13
RU - Federazione Russa 13
JO - Giordania 12
SA - Arabia Saudita 12
VE - Venezuela 12
CL - Cile 11
CA - Canada 10
MA - Marocco 10
NL - Olanda 10
TN - Tunisia 10
KE - Kenya 8
NP - Nepal 7
PY - Paraguay 7
AL - Albania 6
OM - Oman 6
PL - Polonia 6
UA - Ucraina 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 4
EG - Egitto 4
ES - Italia 4
GH - Ghana 4
TH - Thailandia 4
AU - Australia 3
AZ - Azerbaigian 3
ET - Etiopia 3
KZ - Kazakistan 3
RO - Romania 3
DK - Danimarca 2
FI - Finlandia 2
HR - Croazia 2
IE - Irlanda 2
KG - Kirghizistan 2
KR - Corea 2
PE - Perù 2
QA - Qatar 2
TT - Trinidad e Tobago 2
YE - Yemen 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GF - Guiana Francese 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
LB - Libano 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MZ - Mozambico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TW - Taiwan 1
Totale 2.713
Salva come PNG Salva come JPEG
Città #
San Jose 418
Singapore 203
Rome 163
Hong Kong 150
Ashburn 146
Beijing 107
Mexico City 36
Ho Chi Minh City 29
Hanoi 23
Milan 15
Santa Clara 15
Baghdad 14
São Paulo 14
Tashkent 13
Amman 10
Rio de Janeiro 10
Karachi 9
Caracas 8
Frankfurt am Main 8
Florence 7
Porto Alegre 7
Quito 7
Belo Horizonte 6
Dhaka 6
Guayaquil 6
Johannesburg 6
Nairobi 6
Perugia 6
Aci Catena 5
Brasília 5
Brescia 5
Casablanca 5
Delhi 5
Jeddah 5
Kaithal 5
Kuala Lumpur 5
Ribeirão Preto 5
Accra 4
Benevento 4
Contagem 4
Cotia 4
Curitiba 4
Izmir 4
Manaus 4
Medellín 4
Montevideo 4
Muscat 4
Naples 4
Riyadh 4
Salvador 4
Santiago 4
Tirana 4
Tunis 4
Addis Ababa 3
Ankara 3
Baku 3
Betim 3
Bucharest 3
Chicago 3
Cincinnati 3
Council Bluffs 3
Da Nang 3
Decatur 3
Duque de Caxias 3
Fortaleza 3
Guarujá 3
Guarulhos 3
Haiphong 3
Hamilton 3
Jakarta 3
Kathmandu 3
Lahore 3
Madrid 3
Manila 3
Mumbai 3
Necochea 3
New York 3
Paranaque City 3
Picos 3
Pune 3
Sermoneta 3
Thái Nguyên 3
Toronto 3
Wroclaw 3
Abu Dhabi 2
Alexandria 2
Ambāla 2
Amparo 2
Apucarana 2
Araras 2
Araçatuba 2
Aryanah 2
Asunción 2
Atlanta 2
Bagé 2
Bauru 2
Belém 2
Bengaluru 2
Bishkek 2
Boardman 2
Totale 1.682
Salva come PNG Salva come JPEG
Nome #
Understanding the use of prescription and OTC drugs in obtaining highs and the pharmacist role in preventing abuse 123
Le nuove sostanze psicoattive 52
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) 44
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases 42
Nuove frontiere nell'abuso di sostanze, psiconauti e internet 41
Evaluating craving in Alcohol Use Disorder: psychometric characteristics of the Craving Typology Questionnaire-15 (CTQ-15) 41
'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports 41
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 40
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases 39
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): An Analysis of Pharmacovigilance Databases 37
Utilizzo del pregabalin nel trattamento del gioco d'azzardo patologico: dati preliminari 37
The e-psychonaut drugs' psychopharmacology 36
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 34
A multidisciplinary approach for addiction treatment in an Italian day hospital service: a therapy model and its goals 33
Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports 33
Knowledge and use of over-the-counter drugs in Italy: an exploratory survey-based study in the general population 33
A decade of gabapentinoid misuse: an analysis of the European Medicines Agency's ‘suspected adverse drug reactions' database. Assessment of gabapentinoid misuse/dependence as reported to the EMA 33
Beyond the purple drank. Study of promethazine abuse according to the Eurovigilance dataset 33
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review 33
Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review 32
Assessing The 2004-2018 Fentanyl Misusing Issues Reported To An International Range Of Adverse Reporting Systems 32
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 32
Evaluation of an italian sample of gamblers with dannon ainhold gambling scale: preliminary study 31
Gestione dei pazienti con depressione resistente al trattamento in comorbilità con il disturbo da uso di sostanze: sicurezza ed efficacia dell'esketamina in un sottocampione di pazienti dello studio REAL-ESK 31
Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel 31
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 31
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice 30
Methoxetamine: An Analogue of Ketamine 30
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults 30
2876 – Glutamatergic strategies in the treatment of pathological gambling: a pilot study 30
Cannabidiol (CBD) Use in Psychiatric Disorders: a Systematic Review 30
Behavioural changes in cocaine dependent patients after group-therapy 30
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 29
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset 29
New/emerging psychoactive substances and associated psychopathological consequences. 29
Addiction: a therapeutic model for the restructuring of identity 29
Climate change, biodiversity loss and mental health: a global perspective 29
The role of novel psychoactive substances (NPS) in mental health care of young people: a systematic review 29
Fatalities Associated with Mephedrone in Combination with Other Stimulant Drugs in Young People Aged 16-24 Years 29
‘Z-trip'? A comprehensive overview and and a case-series of Zolpidem misuse 29
ARE Z-DRUGS SAFE? STUDY OF THEIR MISUSE, ABUSE AND DEPENDENCE ACCORDING TO THE EUROPEAN MEDICINES AGENCY (EMA) PHARMACOVIGILANCE DATABASE. 28
Age in Pathological Gambling: Correlations with Personality and Psychiatric Comorbidity. 28
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 27
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. 27
β-2 agonists as misusing Drugs? Assessment of both Clenbuterol- and Salbutamol-related European Medicines Agency (EMA) Pharmacovigilance Database Reports. 27
Mobile phone use during adolescence: a new addiction? 27
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 27
Is there a potential of misuse for quetiapine? Literature review and analysis of the European Medicines Agency/EMA Adverse Drug Reactions' database 27
Psychopathologic aspects of obesity: Psychodiagnostic evaluations of bariatric surgery applicants 27
Pregabalin treatment in pathological gambling: a preliminary study 27
COVID-19: The hidden impact on mental health and drug addiction 27
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review 27
Relationship between impulsivity, mood disorders and personality traits in a sample of pathological gamblers 27
Brexpiprazole as a new approach of treatment in somatization disorder 26
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 26
Psychobiological, medical, and psychiatric implications of new/novel psychoactive substance (NPS) use 26
The opioid epidemic over the past 10 years: pharmacovigilance signals from the European Medicines Agency (EMA) and the FDA Adverse Event Reporting System (FAERS) 26
There is a potential of misuse for venlafaxine and bupropion? 26
Validation of a diagnostic questionnaire based on DSM-IV criteria for gambling. 26
Psychosocial risk factors for postpartum depression: a descriptive sample of pregnants 26
Substance-Use Disorders and Violence 26
The bridge between classical and ‘synthetic'/chemical psychoses: towards a clinical, psychopathological and therapeutic perspective 25
Ibogaine/Noribogaine in the treatment of Substance Use Disorders: a systematic review and Meta-analysis of side effects 25
Pharmacovigilance signals of the opioid epidemic over 10 years: an analysis of pharmacovigilance datasets collecting Adverse Drug Reactions (ADRs) reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS) 25
NPS stimulants 25
Beyond the ‘purple drank’. Study of promethazine abuse according to the European Medicines Agency (EMA) Adverse Drug Reactions (ADR) reports 25
Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction 25
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 24
Efficacy of psychosocial and psychological interventions in addition to drug therapy to improve global functioning of inpatients with schizophrenia spectrum and mood disorders: a real-world observational study 24
Behavioural Addictions In Adolescence: Findings From An Italian Survey 24
Online Gambling, Impulsivity and Personality Traits: an Italian Sample 24
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward 24
Pregabalin: a range of misuse-related unanswered questions 23
An insight into Z-drugs abuse and dependence: an examination of reports to the European Medicines Agency (EMA) database of suspected Adverse Drug Reactions (ADR) 23
Alprazolam-related deaths in Scotland, 2004-2020 23
The Unregulated Psychoactive Compound: ‘Benzo Fury' 23
Misuse of Anticholinergic Medications: A Systematic Review 23
New psychoactive substances and suicidality: A systematic review of the current literature 23
Loperamide diversion and abuse: assessment of its non-medical use through the analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports 23
What about “pharming”? Issues regarding the misuse of prescription and over-the-counter drugs 22
The misuse of prescription drugs in the digital era: pros and cons 22
Compulsiveness dimension in a case of pathological gambling 22
The benzydamine experience: a systematic review of benzydamine abuse 22
Misuse and Abuse of Prescription Drugs in Custodial Settings 22
Special M related fatalities in the UK. 21
An Update on Psychoactive Substances: Pharmacology and Toxicology Issues 20
Cannabis: evidenze epidemiologiche, cliniche e terapeutiche 19
New psychoactive substances (NPS), psychedelic experiences, and dissociation; clinical and clinical pharmacological issues. 19
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History 19
Opioid painkiller dependence in a sample of elderly medical inpatients 19
Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports 19
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy 18
Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database 17
To bridge or not to bridge: Moral Judgement in Cocaine Use Disorders, a case-control study on human morality. 16
Totale 2.726
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.982
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20241 0 0 0 0 0 0 0 0 0 0 0 1
2024/2025777 21 99 3 0 22 12 61 128 56 38 188 149
2025/20261.948 122 25 154 158 243 169 191 111 573 202 0 0
Totale 2.726